How should we judge the efficacy of drug therapy in patients with chronic congestive heart failure? The insights of six blind men

This publication has 34 references indexed in Scilit:

• Long-term indoramin therapy in congestive heart failure: A double-blind, randomized, parallel placebo-controlled trial
  Journal of the American College of Cardiology, 1987
• Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.
  Heart, 1985
• Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.
  Circulation, 1985
• Vasodilator and inotropic therapy for severe chronic heart failure: Passion and skepticism
  Journal of the American College of Cardiology, 1983
• A placebo-controlled trial of captopril in refractory chronic congestive heart failure
  Journal of the American College of Cardiology, 1983
• Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.
  Circulation, 1983
• Assessment of vasodilator therapy in patients with severe congestive heart failure: Limitations of measurements of left ventricular ejection fraction and volumes
  The American Journal of Cardiology, 1982
• Hydralazine in the long-term treatment of chronic heart failure: Lack of difference from placebo
  American Heart Journal, 1982
• Long-term therapy of heart failure with prazosin: A randomized double blind trial
  Published by Elsevier ,1980
• Effects of nitroglycerin on left ventricular cavitary size and cardiac performance determined by ultrasound in man
  The American Journal of Medicine, 1974